Innovative Medicines

Coordinator: Santiago Almazán, MERCK

Mission:

The Group aims to be "the voice of innovative medicines in Spain", and promote the creation of an economic, bioethical and social environment at the same time innovative and dynamic to make possible the access to medical biotechnology in our country.

Latest activities:

Position Paper on biosimilars. Allegations to the European directive on "Advanced Therapies". Position Paper on the National Rare Diseases Strategy of the National Health System. Preparation of the 2010 Red Biotech Pipeline.

Documents:

Spanish Red Biotech PIPELINE 2010		Descargar archivo
Posicionamiento Estrategia Nacional EERR del SNS		Descargar archivo
Biosimilares Documento de Posición de ASEBIO		Descargar archivo

Members:

• 3P BIOPHARMACEUTICALS
• ADVANCELL
• ALLINKY BIOPHARMA
• AMGEN
• ARCHIVEL PHARMA
• ASCIDEA
• BIOBIDE
• BIOBASQUE
• BIOMARIN
• BIOMOL-INFORMATICS
• BIONANOPLUS
• BIONATURIS
• BIONOSTRA
• BIOPOLIS
• BIOSERENTIA - BIOTECH ACCELERATOR
• BIOT
• BIOTOOLS
• BIOVAL
• BTI
• CAIBER
• CANVAX BIOTECH
• CIBER BBN
• CIBER ER
• CSIC
• CYTOGNOS
• DIGNA BIOTECH
• DIOMUNE
• ENTRECHEM
• ERA7 INFORMATION TECHNOLOGIES, S.L.U
• FUNDACIÓN INBIOMED
• FUNDACIÓN MEDINA
• GAIKER
• GENETRIX-Cellerix
• GENOMICA, S.A.U
• GENZYME
• GILEAD SCIENCES, S.L.
• GRADOCELL
• GRIFOLS
• GP-PHARM
• GRUPO P-VALUE
• INGENIATRICS
• INSTITUTO BIOMAR
• INSTITUTO UNIVERSITARIO DE CIENCIA Y TECNOLOGÍA (IUCT)
• LEITAT (Centro Tecnológico)
• LABORATORIOS ESTEVE
• LABORATORIOS LETI, S. L. U
• LABORATORIOS SANIFIT
• LAIMAT
• MERCK S.L.(coordinador)
• MSD
• MICROBIONTA (BIONOSTRA)
• MILTENYI BIOTECH
• NEURON BIO
• NEUROSCIENCES TECHNOLOGIES
• NEUROTEC PHARMA
• NOSCIRA
• OMNIA MOLECULAR
• ORYZON GENOMICS
• PALAU PHARMA
• FUNDACIÓN PARQUE CIENTÍFICO DE MADRID
• PHARMAMAR (ZELTIA)
• PROTEOMIKA
• PROTEOS BIOTECH
• SISTEMAS GENÓMICOS
• SUANFARMA BIOTECH SGECR S.A
• VALENTIA BIOPHARMA
• VIVACELL
• VIVIA BIOTECH
• ZELTIA